Skip to content

Clinical trials

Observational Rectal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Observational Clear all

481 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20024
20035
20043
20058
200614
20079
200819
200920
201010
201114
201219
201316
201415
201514
201619
201721
201826
201921
202045
202134
202234
202331
202426
202519
202625

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed224
Unknown status114
Recruiting63
Not yet recruiting28
Active, not recruiting24
Terminated15
Withdrawn9
Enrolling by invitation4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sixth Affiliated Hospital, Sun Yat-sen University14
Sahlgrenska University Hospital10
Memorial Sloan Kettering Cancer Center8
Sun Yat-sen University8
Fondazione Policlinico Universitario Agostino Gemelli IRCCS7
Yanhong Deng7
Beijing Friendship Hospital6
Case Comprehensive Cancer Center6
Stanford University6
Alliance for Clinical Trials in Oncology5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms481
Colonic Neoplasms118
Colorectal Neoplasms79
Breast Neoplasms28
Pancreatic Neoplasms28
Prostatic Neoplasms25
Neoplasms23
Lung Neoplasms22
Stomach Neoplasms20
Carcinoma, Non-Small-Cell Lung16

Trials

Showing 76 to 100 of 481. Each trial links to its page on Pharma Observatory.

381 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.